S 2620 · 119th Congress · Health

REMEDY Act

Introduced 2025-07-31· Sponsored by Sen. Durbin, Richard J. [D-IL]· Senate

Bill Progress

Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5000)(2025-07-31)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 2620 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 2620 To amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES July 31, 2025 Mr. Durbin (for himself and Mr. Cassidy) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Reforming Evergreening and Manipulation that Extends Drug Years Act'' or the ``REMEDY Act''. SEC. 2. AMENDMENTS TO ANDA APPROVAL PROVISIONS. Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended-- (1) in subsection (c)(2) by adding at the end the f…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (1)

1 Republican